Potently neutralizing and protective human antibodies against SARS-CoV-2

Journal: Nature

Published: 2020-07-15

DOI: 10.1038/s41586-020-2548-6

Affiliations: 14

Authors: 41

Go to article
Institutions Share
Vanderbilt University Medical Center (VUMC), United States of America (USA) 0.35
Washington University in St. Louis (WUSTL), United States of America (USA) 0.29
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA) 0.10
The University of North Carolina at Chapel Hill (UNC), United States of America (USA) 0.10
AstraZeneca Gaithersburg, MD, United States of America (USA) 0.10
Yogi Vemana University (YVU), India 0.04
Monroe Carell Jr. Children's Hospital, VU, United States of America (USA) 0.02
Leipzig University, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER